Hepatic Safety of Ozanimod in Ulcerative Colitis and Relapsing Multiple Sclerosis Phase 3 Trials

Authors
Category Primary study
JournalAmerican Journal of Gastroenterology
Year 2022
This article has no abstract
Epistemonikos ID: 1ae031304515e06986f8f18bf4be893e9d691b41
First added on: Feb 15, 2025